Calamos Advisors LLC Nevro Corp Transaction History

Calamos Advisors LLC

  • $16.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 12, 2021
SELL
$132.81 - $182.18 $1.46 Million - $2.01 Million
-11,010 Closed
0 $0
Q4 2020

Jan 27, 2021
SELL
$138.17 - $184.34 $323,594 - $431,724
-2,342 Reduced 17.54%
11,010 $1.91 Million
Q3 2020

Oct 26, 2020
BUY
$114.09 - $145.51 $1.52 Million - $1.94 Million
13,352 New
13,352 $1.86 Million

Others Institutions Holding NVRO

# of Institutions
151
Shares Held
39.3M
Call Options Held
67.9K
Put Options Held
1.59M
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $116M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email